ACCENDRA HEALTH INC/VA/ ACH

NYSE Price as of Nov 13, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$0.1300
$0.1200
$4.69
Market cap
$10.00M
P/E (GAAP, TTM)
—
P/E (operating)
0.46
Dividend yield
0.0%
Revenue growth YoY
-13.7%
EPS growth YoY
87.1%
ROIC
—
Piotroski F-score
2

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
—

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
0.46

After-tax operating income only: the core business.

P/E (excl. gains)
—

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ 2025Q3Change YoY
Revenue growth YoY (qtr) -10.1% -6.8%-3.2 pts 3.3%-13.3 pts
EPS growth YoY (qtr) 89.7% 75.0%+14.7 pts -2,590.5%+2,680.2 pts
Revenue growth (TTM) 247.0% 266.4%-19.3 pts 3.1%+243.9 pts
EPS growth (TTM) 74.9% -195.6%+270.5 pts -2,743.6%+2,818.5 pts
P/E (GAAP, TTM) — —— ——
P/E (operating) 2.02 12.12-10.10 ——
P/E (excl. gains) — —— ——
P/B — —— ——
ROIC — —— -28.6%—
Net margin -39.8% -39.8%0.0 pts -13.5%-26.3 pts
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) -3.93 -14.07+72.1% -15.64+74.9%
Price $0.5700 $3.42-83.3% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $601.78M -1.9% -13.7% -0.25 78.4% 87.1% -3.3%
Jun 30, 2026 $613.23M -2.3% -10.1% -1.16 -1,350.0% 89.7% -14.5%
Mar 31, 2026 $627.78M -11.5% -6.8% -0.08 89.3% 75.0% -1.0%
Dec 31, 2025 * $708.97M 1.7% 155.4% -0.75 61.3% 80.6% -7.9%
Sep 30, 2025 $697.26M 2.3% 1.5% -1.94 82.8% -1,112.5% -21.6%
Jun 30, 2025 $681.92M 1.2% 3.3% -11.30 -3,431.3% -2,590.5% -127.4%
Mar 31, 2025 $673.88M 152.7% -74.2% -0.32 91.7% -10.3% -3.7%
Dec 31, 2024 * -$1.28B -286.3% 75.0% -3.86 -2,312.5% -1,708.3% 23.1%
Sep 30, 2024 $686.85M 4.0% -73.5% -0.16 61.9% -100.0% -1.9%
Jun 30, 2024 $660.40M -74.7% -74.2% -0.42 -44.8% -13.5% -4.8%
Mar 31, 2024 $2.61B 151.0% 3.6% -0.29 -220.8% 9.4% -0.8%
Dec 31, 2023 * -$5.13B -297.8% -300.9% 0.24 400.0% 131.6% -0.3%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 13, 2026 Date of the latest closing price used.
Price $0.1300 Latest closing price.
Market cap $10.00M Price × shares outstanding.
Enterprise value -$21.99M Market cap + debt − cash: the price of the whole business.
Shares 76.92M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) — Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) 0.46 Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) 3.00 Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) — Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield -11,006.2% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -1,723.1% TTM EPS ÷ price.
P/B — Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 0.00 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 0.00 Market cap ÷ revenue of the last four quarters.
P/FCF — Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA -0.09 Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT -0.80 Enterprise value ÷ operating income.
EV/Sales -0.01 Enterprise value ÷ revenue.
Book value / share — Shareholders' equity ÷ shares.
FCF yield — Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS 0.28 After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains $27.27M One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income -$129.41M Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 2.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $601.78M Revenue of the latest reported quarter.
Net income (qtr) -$19.70M Net income of the latest reported quarter.
EPS (qtr) -0.25 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) -13.7% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) -1.9% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) 87.1% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 78.4% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) 86.9% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 77.9% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) 0.2% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) -3.3% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $2.55B Revenue of the last four quarters.
Net income (TTM) -$171.56M Net income of the last four quarters.
EPS (TTM) -2.24 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 230.0% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 87.1% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 87.2% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio — Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio — Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date Jun 22, 2023 Most recent ex-dividend date.
Buyback yield 101.8% Share repurchases ÷ market cap.
Shareholder yield 101.8% Dividend yield + buyback yield.
Profitability
Gross margin 46.7% Gross profit ÷ revenue (latest fiscal year).
EBITDA margin 8.8% EBITDA ÷ revenue.
Operating margin 1.0% Operating income ÷ revenue.
Net margin -39.8% Net income ÷ revenue.
FCF margin — Free cash flow ÷ revenue.
ROE — Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA -44.9% Return on assets: net income ÷ total assets.
ROIC — Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 3.1% Latest fiscal year revenue vs the year before.
Net income growth (annual) -203.5% Latest fiscal year net income vs the year before.
EPS growth (annual) -202.5% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) -34.8% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 0.58 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 0.50 (Current assets − inventory) ÷ current liabilities.
Cash ratio 0.30 Cash ÷ current liabilities.
Debt / equity — Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.10 Total debt ÷ total assets.
Debt / EBITDA 1.03 Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA -0.13 (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage 0.26 Operating income ÷ interest expense.
Earnings quality
FCF conversion — Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio — (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 0.5% Share-based compensation ÷ revenue.
R&D % revenue — Research & development spending ÷ revenue.
SG&A % revenue 38.7% Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 1.13 Revenue ÷ total assets.
Days sales outstanding — Average days to collect payment from customers.
Days inventory 18 Average days inventory is held.
Days payables 90 Average days to pay suppliers.
Trading & momentum
52-week high $4.69 Highest price in the last 52 weeks.
52-week low $0.1200 Lowest price in the last 52 weeks.
From 52-week high -97.2% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 8.3% How far above the 52-week low the price is.
Avg volume (30d) 3.91M Average shares traded per day over the last 30 days.
Avg $ volume (30d) $917.88K Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 2 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 0.35 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $2.76B Revenue of the latest fiscal year.
Net income -$1.10B Net income of the latest fiscal year.
Diluted EPS -14.31 Diluted earnings per share of the latest fiscal year.
EBITDA $241.98M Operating income + depreciation & amortization.
Free cash flow — Operating cash flow − capital spending.
Total debt $250.00M Long-term plus current debt.
Cash $281.99M Cash and equivalents.
Equity -$460.98M Shareholders' equity.
Total assets $2.45B Total assets.